California Public Employees Retirement System’s Crinetics Pharmaceuticals CRNX Stock Holding History

California Public Employees Retirement System’s Portfolio CRNX Stock Details CRNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-54,800	Closed	-$837K	–	1866
2021 Q1	$837K	Sell	54,800 -5,048	-8%	-$78.2K	﹤0.01%	2612
2020 Q4	$844K	Sell	59,848 -1,200	-2%	-$16.7K	﹤0.01%	2596
2020 Q3	$957K	Buy	61,048 +6,248	+11%	+$95.5K	﹤0.01%	2311
2020 Q2	$960K	Buy	54,800 +35,700	+187%	+$609K	﹤0.01%	2267
2020 Q1	$281K	Hold	19,100	–	–	﹤0.01%	2687
2019 Q4	$479K	Buy	+19,100	New	+$364K	﹤0.01%	2760

Other funds holding CRNX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

NLVP

New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

5VM

5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return

California Public Employees Retirement System's CRNX Position: Q2 2021 in Review

California Public Employees Retirement System sold out of Crinetics Pharmaceuticals (CRNX) in Q2 2021, closing a stake of 54,800 shares — an estimated $837K sold.

California Public Employees Retirement System first reported a position in CRNX in Q4 2019 and held it in 6 quarters. The position peaked at $960K in Q2 2020. 83 funds tracked by Wall St. Rank hold CRNX as of Q2 2021.

California Public Employees Retirement System reported no remaining Crinetics Pharmaceuticals position as of Q2 2021 after selling out during the quarter.
California Public Employees Retirement System sold 54,800 Crinetics Pharmaceuticals shares in Q2 2021, an estimated $837K.
California Public Employees Retirement System first reported a position in Crinetics Pharmaceuticals in Q4 2019 and held it in 6 quarters.
California Public Employees Retirement System's Crinetics Pharmaceuticals position peaked at $960K in Q2 2020.
83 funds tracked by Wall St. Rank held Crinetics Pharmaceuticals as of Q2 2021.

Based on California Public Employees Retirement System's 13F filing for Q2 2021, filed 13 Aug 2021.